This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Woman in consultation

    Defining the threshold of permissive renal function decline in heart failure

  • Associations between changes in kidney function and volume status with heart failure outcomes

  • Ethnic differences in CKD progression among people with type 2 diabetes

  • Growing CONFIDENCE in co-prescribing of SGLT2 inhibitors and non-steroidal MRAs

  • Combination finerenone and empagliflozin in CKD with diabetes

  • Acute myocardial infarction management by kidney function across hospitals in England

  • The KFRE: does our clinical practice limit its theoretical benefits?

  • Kidney failure risk equation and health inequalities in routine care

  • SOUL: effects of oral semaglutide and cardiovascular outcomes independent of SGLT2 inhibitor use

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe